- Home
- CWAN vs MASI Comparison
CWAN vs MASI Comparison
Compare CWAN & MASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWAN
- MASI
- Stock Information
- Founded
- CWAN 2004
- MASI 1989
- Country
- CWAN United States
- MASI United States
- Employees
- CWAN N/A
- MASI N/A
- Industry
- CWAN Computer Software: Prepackaged Software
- MASI Medical/Dental Instruments
- Sector
- CWAN Technology
- MASI Health Care
- Exchange
- CWAN Nasdaq
- MASI Nasdaq
- Market Cap
- CWAN 6.1B
- MASI 8.2B
- IPO Year
- CWAN 2021
- MASI 2007
- Fundamental
- Price
- CWAN $22.06
- MASI $160.04
- Analyst Decision
- CWAN Buy
- MASI Buy
- Analyst Count
- CWAN 10
- MASI 6
- Target Price
- CWAN $31.50
- MASI $187.00
- AVG Volume (30 Days)
- CWAN 4.1M
- MASI 557.6K
- Earning Date
- CWAN 07-30-2025
- MASI 08-05-2025
- Dividend Yield
- CWAN N/A
- MASI N/A
- EPS Growth
- CWAN N/A
- MASI N/A
- EPS
- CWAN 1.71
- MASI N/A
- Revenue
- CWAN $475,948,000.00
- MASI $2,126,800,000.00
- Revenue This Year
- CWAN $63.43
- MASI N/A
- Revenue Next Year
- CWAN $29.94
- MASI $7.74
- P/E Ratio
- CWAN $12.87
- MASI N/A
- Revenue Growth
- CWAN 23.21
- MASI 16.68
- 52 Week Low
- CWAN $18.75
- MASI $101.61
- 52 Week High
- CWAN $35.71
- MASI $194.88
- Technical
- Relative Strength Index (RSI)
- CWAN 46.53
- MASI 42.81
- Support Level
- CWAN $21.68
- MASI $161.18
- Resistance Level
- CWAN $22.92
- MASI $168.81
- Average True Range (ATR)
- CWAN 0.66
- MASI 4.57
- MACD
- CWAN 0.04
- MASI -1.01
- Stochastic Oscillator
- CWAN 43.46
- MASI 1.76
About CWAN Clearwater Analytics Holdings Inc.
Clearwater Analytics describes its mission as aiming to be the world's most trusted and comprehensive technology platform for the entire investment cycle. Clearwater has historically focused on back-office functions such as investment accounting, but with acquisitions such Enfusion, Beacon, and Bistro, the firm has broadened its focus with front-office and middle-office capabilities. Clearwater primarily serves insurance companies, asset managers, hedge funds, and corporate treasuries. Pro forma for Enfusion, about 76% of Clearwater's revenue is generated in the US.
About MASI Masimo Corporation
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.